Cosmos Health (COSM) Change in Inventory (2016 - 2026)
Cosmos Health's (COSM) quarterly Change in Inventory came in at -$1.1 million in Q2 2026, down 3062.49% on a YoY basis from $37514.5 in Q2 2025, and down 5023.84% quarter-over-quarter from -$21690.0 in Q1 2026.
Analysis
Cosmos Health (COSM) Change in Inventory (2016 - 2026) Analysis & Trends
Cosmos Health (COSM) has reported Change in Inventory for 11 consecutive years, with -$1.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Inventory fell 3062.49% year-over-year to -$1.1 million; the trailing twelve-month figure through Jun 2026 stood at -$460726.0 (down 237.68% YoY), and the FY2025 full-year result was $829975.0, up 666.73% from the prior year.
- Change in Inventory retreated to -$1.1 million in Q2 2026 per COSM's latest filing, from -$21690.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $1.9 million in Q4 2022 and bottomed at -$1.7 million in Q2 2022.
- Historically, Change in Inventory has averaged $51491.4 across 5 years, with a median of $137615.0 in 2023.
- The sharpest annual moves came in 2022 and 2026: Change in Inventory surged 579.38% in 2022, then sank 3062.49% in 2026.
- Over 5 years, Change in Inventory stood at $1.9 million in 2022, then tumbled by 175.01% to -$1.4 million in 2023, then surged by 86.32% to -$192752.0 in 2024, then surged by 153.0% to $102151.0 in 2025, then slumped by 1187.96% to -$1.1 million in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered -$1.1 million, -$21690.0, and $102151.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | -59.00 Mn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 99.50 Mn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | -76.69 Mn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 69.19 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 22.00 Mn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | -403,000.00 |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | -305,000.00 |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 9.88 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | - |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn | -1.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.11 Mn |
| Mar 31, 2026 | -21,690.00 |
| Dec 31, 2025 | 102,151.00 |
| Sep 30, 2025 | 570,174.00 |
| Jun 30, 2025 | -35,142.00 |
| Mar 31, 2025 | 192,792.00 |
| Dec 31, 2024 | -192,752.00 |
| Sep 30, 2024 | 369,737.00 |
| Jun 30, 2024 | -519,456.00 |
| Mar 31, 2024 | 196,020.00 |
| Dec 31, 2023 | -1.41 Mn |
| Sep 30, 2023 | 1.35 Mn |
| Jun 30, 2023 | 173,079.00 |
| Mar 31, 2023 | 776,554.00 |
| Dec 31, 2022 | 1.88 Mn |
| Sep 30, 2022 | -674,984.00 |
| Jun 30, 2022 | -1.65 Mn |
| Mar 31, 2022 | 934,400.00 |
| Dec 31, 2021 | -391,827.00 |
| Sep 30, 2021 | 817,456.00 |